These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


355 related items for PubMed ID: 1714270

  • 1. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Aug; 109(8):1109-14. PubMed ID: 1714270
    [Abstract] [Full Text] [Related]

  • 2. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1986 May; 104(5):694-701. PubMed ID: 2423061
    [Abstract] [Full Text] [Related]

  • 3. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [Abstract] [Full Text] [Related]

  • 4. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
    [Abstract] [Full Text] [Related]

  • 5. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1986 Apr; 104(4):503-12. PubMed ID: 2420315
    [Abstract] [Full Text] [Related]

  • 6. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):832-7. PubMed ID: 1693498
    [Abstract] [Full Text] [Related]

  • 7. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [Abstract] [Full Text] [Related]

  • 8. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Sep; 109(9):1232-41. PubMed ID: 1718251
    [Abstract] [Full Text] [Related]

  • 9. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Sep; 109(9):1220-31. PubMed ID: 1718250
    [Abstract] [Full Text] [Related]

  • 10. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1.
    Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg P, Thomas MA, Submacular Surgery Trials Pilot Study Investigators.
    Am J Ophthalmol; 2000 Oct; 130(4):387-407. PubMed ID: 11024412
    [Abstract] [Full Text] [Related]

  • 11. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
    [Abstract] [Full Text] [Related]

  • 12. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ, Friberg TR, Stickney KL, Akduman L, Wong KL, Chen MC, Levy MH, Garcia CA, Morse LS.
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [Abstract] [Full Text] [Related]

  • 14. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of macular choroidal neovascular membrane with krypton red laser photocoagulation].
    Sun XQ.
    Zhonghua Yan Ke Za Zhi; 1989 Mar; 25(2):94-6. PubMed ID: 2477203
    [Abstract] [Full Text] [Related]

  • 16. Scatter macular photocoagulation for subfoveal neovascular membranes in age-related macular degeneration. A pilot study.
    Tornambe PE, Poliner LS, Hovey LJ, Taren D.
    Retina; 1992 Mar; 12(4):305-14. PubMed ID: 1283021
    [Abstract] [Full Text] [Related]

  • 17. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group.
    Willan AR, Cruess AF, Ballantyne M.
    Can J Ophthalmol; 1996 Feb; 31(1):11-7. PubMed ID: 8925479
    [Abstract] [Full Text] [Related]

  • 18. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1987 Nov; 105(11):1499-507. PubMed ID: 2445326
    [Abstract] [Full Text] [Related]

  • 19. Laser treatment of macular disease.
    Bass SJ, Giovinazzo V.
    Optom Clin; 1996 Nov; 5(1):161-73. PubMed ID: 8963076
    [Abstract] [Full Text] [Related]

  • 20. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1989 Mar; 107(3):344-52. PubMed ID: 2466454
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.